Novel Modified Release Dosage Forms Of Xanthine Oxidoreductase Inhibitor Or Xanthine Oxidase Inhibitors - EP2582812
The patent EP2582812 was granted to Takeda Pharmaceuticals USA on Jan 24, 2018. The application was originally filed on Jun 15, 2011 under application number EP11796331A. The patent is currently recorded with a legal status of "No Opposition Filed Within Time Limit".
EP2582812
- Application Number
- EP11796331A
- Filing Date
- Jun 15, 2011
- Status
- No Opposition Filed Within Time Limit
- Nov 30, 2018
- Grant Date
- Jan 24, 2018
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents